Biotech Companies

“The first is the amount of market cap added to Lilly and Novo based on the, you know, development of GLP ones. It's like over a trillion dollars is, is more, you know, I mean, NOAA stock has decreased a lot. So you know, trillion dollars, let's say, is more th…”

“And then eventually I decided, you know what? Fuck it. I want to give it a try. I wanna, you know, just learn, and so I hired a biology tutor. I, like, digested all the information, and I brought in people who've been Running biotech companies and who had been…”

“So I would say those biotech companies, so the, of the targets the ones that are, that have the best seat in the house are the ones that are developing drugs that have the potential to move the needle for a pharma. So it has to be a blockbuster drug and is in …”

“One particular example that we find kind of interesting is that companies that actually have succeeded all the way, you know, through development, and they're getting ready to launch a product, but that product is a sub one billion dollar peak sales product. C…”

“Now, after that, you get to a point where actually 200 different companies were trading below the levels of cash on their balance sheet. That's highly unusual. We've never seen that before, even going back to The global financial crisis and the bear market, th…”

“The reason they exist is that pharma is not good at R&D. These little firms all do R&D. They do drug discovery on the path to drug commercialization, and what we find, you know, they exist because pharma isn't good at it, and the capital markets have figured o…”

“She's also a part-time partner at YC, which means in her free time, she helps all our biotech companies at which, at this point it's like hundreds, I don't know what the exact number is, but hundreds of biotech companies.”

“For a biotech company that's in the therapeutic space, you know, really you're not going to have any commercial revenue until you have an approved product that is sold on the market, which actually most biotechs never have.”

“You know, I think one of the most frustrating things is that the companies that get the most funding aren't the companies I wish got the most funding. I work with a lot of really interesting, like biotech companies, people working on some really interesting pr…”

“So they may not make, you know, a really significant advancement in terms of the experimental work, but they certainly will make a significant advancement in terms of understanding the market and understanding what steps are required To get to the market in a …”

“So if they can outsource those experiments, then they'll often be able to get results quickly, and we have had a lot of success with that with our biotech companies where they've actually worked with external companies that are already up and running to do, fo…”

“I think one of the interesting differences between biotech companies and sort of software, just tech companies is that the actual market, there's not really that, that question. Like if you're a biotech company and you're going to cure Alzheimer's disease, the…”

“And you look at just in the past gosh, I mean, the past three years 2013, 20 14, 2015, and the interesting thing is that the majority of the IPOs in each of the That period where were biotech companies, which historically is only about 20% of the money, but ma…”